The Latest Clinical Study on GLP-1 Receptor Agonists episode artwork

EPISODE · Sep 23, 2025 · 38 MIN

The Latest Clinical Study on GLP-1 Receptor Agonists

from Redox Revolution · host William Seeds, MD

In this podcast, Dr. Seeds addresses a recent clinical study that advances the effectiveness of GLP-1 receptor agonists like semaglutide (trade name Ozempic) as an anti-aging treatment. Follow for more!Instagram: @williamseedsmd | @redoxmedicalgroupYoutube: Subscribe Here

In this podcast, Dr. Seeds addresses a recent clinical study that advances the effectiveness of GLP-1 receptor agonists like semaglutide (trade name Ozempic) as an anti-aging treatment. Follow for more! Instagram: @williamseedsmd | @redoxmedicalgroup Youtube: Subscribe Here

NOW PLAYING

The Latest Clinical Study on GLP-1 Receptor Agonists

0:00 38:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Redox Revolution?

This episode is 38 minutes long.

When was this Redox Revolution episode published?

This episode was published on September 23, 2025.

What is this episode about?

In this podcast, Dr. Seeds addresses a recent clinical study that advances the effectiveness of GLP-1 receptor agonists like semaglutide (trade name Ozempic) as an anti-aging treatment. Follow for more!Instagram: @williamseedsmd |...

Can I download this Redox Revolution episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!